Evaluation of Epithelial–Mesenchymal Transition Markers in Autoimmune Thyroid Diseases
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043359 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Pablo Sacristán-Gómez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Hospital Universitario de la Princesa, Instituto de Investigación Princesa, Universidad Autónoma de Madrid, C/Diego de L…. Hauptthemen laut MEDLINE: Hashimoto Disease, Autoimmune Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMHD NIH HHS, Instituto de Salud Carlos III, Comunidad de Madrid.
Abstract (Originalsprache)
A state of chronic inflammation is common in organs affected by autoimmune disorders, such as autoimmune thyroid diseases (AITD). Epithelial cells, such as thyroid follicular cells (TFCs), can experience a total or partial transition to a mesenchymal phenotype under these conditions. One of the major cytokines involved in this phenomenon is transforming growth factor beta (TGF-β), which, at the initial stages of autoimmune disorders, plays an immunosuppressive role. However, at chronic stages, TGF- β contributes to fibrosis and/or transition to mesenchymal phenotypes. The importance of primary cilia (PC) has grown in recent decades as they have been shown to play a key role in cell signaling and maintaining cell structure and function as mechanoreceptors. Deficiencies of PC can trigger epithelial–mesenchymal transition (EMT) and exacerbate autoimmune diseases. A set of EMT markers (E-cadherin, vimentin, α-SMA, and fibronectin) were evaluated in thyroid tissues from AITD patients and controls through RT-qPCR, immunohistochemistry (IHC), and western blot (WB). We established an in vitro TGF-β–stimulation assay in a human thyroid cell line to assess EMT and PC disruption. EMT markers were evaluated in this model using RT-qPCR and WB, and PC was evaluated with a time-course immunofluorescence assay. We found an increased expression of the mesenchymal markers α-SMA and fibronectin in TFCs in the thyroid glands of AITD patients. Furthermore, E-cadherin expression was maintained in these patients compared to the controls. The TGF-β-stimulation assay showed an increase in EMT markers, including vimentin, α-SMA, and fibronectin in thyroid cells, as well as a disruption of PC. The TFCs from the AITD patients experienced a partial transition to a mesenchymal phenotype, preserving epithelial characteristics associated with a disruption in PC, which might contribute to AITD pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Hospital Universitario de la Princesa, Instituto de Investigación Princesa, Universidad Autónoma de Madrid, C/Diego de León 62, 28006 Madrid, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER GCV14/ER/12), 28029 Madrid, Spain.
- Department of General and Digestive Surgery, Hospital Universitario de la Princesa, Instituto de Investigación Princesa, Universidad Autónoma de Madrid, C/Diego de León 62, 28006 Madrid, Spain.
- Gastroenterology Research Unit, Hospital Universitario de la Princesa, Instituto de Investigación Princesa, Universidad Autónoma de Madrid, C/Diego de León 62, 28006 Madrid, Spain.
- Pathology Unit, Hospital Universitario de la Princesa, Instituto de Investigación Princesa, Universidad Autónoma de Madrid, C/Diego de León 62, 28006 Madrid, Spain.
- Faculty of Medicine, Universidad San Pablo CEU, Urbanización Montepríncipe, Alcorcón, 28925 Madrid, Spain.
ORCID-Profile: José Luis Muñoz-De-Nova, Francisca Molina-Jiménez, Mónica Marazuela, Rebeca Martínez-Hernández
Förderung
- NIMHD NIH HHS
- Instituto de Salud Carlos III
- Comunidad de Madrid
Zitieren
APA
Sacristán-Gómez, P., Serrano-Somavilla, A., Castro-Espadas, L., Sánchez de la Blanca Carrero, N., Sampedro-Núñez, M., Muñoz-De-Nova, J. L., Molina-Jiménez, F., Rosell, A., Marazuela, M., & Martínez-Hernández, R. (2023). Evaluation of Epithelial–Mesenchymal Transition Markers in Autoimmune Thyroid Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043359
Vancouver
Sacristán-Gómez P, Serrano-Somavilla A, Castro-Espadas L, Sánchez de la Blanca Carrero N, Sampedro-Núñez M, Muñoz-De-Nova JL, et al. Evaluation of Epithelial–Mesenchymal Transition Markers in Autoimmune Thyroid Diseases. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043359
BibTeX
@article{SacristnGmez2023,
author = {Sacristán-Gómez, Pablo and Serrano-Somavilla, Ana and Castro-Espadas, Lía and Sánchez de la Blanca Carrero, Nuria and Sampedro-Núñez, Miguel and Muñoz-De-Nova, José Luis and Molina-Jiménez, Francisca and Rosell, Alejandra and Marazuela, Mónica and Martínez-Hernández, Rebeca},
title = {Evaluation of Epithelial–Mesenchymal Transition Markers in Autoimmune Thyroid Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043359}
}
EUVIMED